Hypomethylating agents in myelodysplastic syndromes and population-level outcomes: a changing landscape or a small dent?
Zeidan AM. Hypomethylating agents in myelodysplastic syndromes and population-level outcomes: a changing landscape or a small dent? Leukemia & Lymphoma 2017, 59: 1030-1032. PMID: 28952833, DOI: 10.1080/10428194.2017.1382700.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements